link to HHS Combat Covid

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Click to access mobile menu
Print
  • Share:
Skip Navigation LinksHome > Funding > ODS Research Portfolio > Grant Abstract

Notice: Historical Content
This is an archival or historical document and may not reflect current data.

Grant Abstract: Vitamin B12 status, cognitive decline and incident dementia

Grant Number: 5R01AG059011-02
PI Name: Jacques
Project Title: Vitamin B12 status, cognitive decline and incident dementia

Abstract: The serious neurologic consequences of clinical vitamin B12 deficiency results is well-established, but it is generally believed that undiagnosed B12 deficiency is present in about 5% of those aged =60 y. There is also limited evidence that long-term B12 insufficiency, which may be present in up to 40% of older individuals, leads to neurocognitive dysfunction. However, this relationship remains uncertain because of serious limitations in the existing evidence. Given its high prevalence, it is critical to understand the potential neurocognitive consequences of B12 insufficiency. Many observational and clinical studies have suggested that B12 insufficiency is associated with reduced neurocognitive function in the elderly, but other studies have not. A major reason for these observed inconstancies is the difficulty in determining B12 status. Combining multiple measurements of B12 status, such as circulating B12, total homocysteine and methylmalonic acid, provide a more reliable assessment of B12 status. Another key factor in the discrepancies between studies of B12 status and neurocognitive function is the failure to account for the worsening effect of excess folate on clinical effects of B12 insufficiency. Other limitations of existing studies of B12 and neurocognitive function that may be, in part, responsible for the inconsistent evidence are the lack of repeated assessment of B12 status during follow-up, insufficient numbers of subjects and follow-up duration, and heterogeneity and weaknesses in cognition assessment methodology. Undertaking randomized trials to examine the relationship between B12 insufficiency and cognitive decline is fraught with ethical considerations as it would require that individuals with low B12 levels go untreated for long periods of follow-up. Therefore, gaining a better understanding of B12 insufficiency in neurologic function of aging individuals will require well-designed observational studies. The goal of the proposed project is to address the critical gap in our understanding of B12 status and cognitive function using existing blood samples to assess folate status and B12 status using a combined marker based on the 3 aforementioned markers of B12 status, existing data to characterize B12 intake from dietary supplements, and existing data on cognitive decline, dementia including Alzheimer’s disease, and brain atrophy in up to 3500 individuals followed for 20+ years. These data from the Framingham Heart Study present a unique opportunity to assess the relationship between B12 insufficiency and age-related neurocognitive changes in an efficient and effective manner with few limitations of earlier studies. Findings from the proposed study will provide a scientific basis for treatment of B12 insufficiency and could have a substantial public health impact as B12 insufficiency is common and frequency undiagnosed. Thus, B12 insufficiency may be an important missed opportunity for prevention of age-related neurocognitive decline and dementia as it can be easily identified and treated with B12 supplements.

Back to Grants Page